- Corporate Governance
- Information to the Swedish Markets
- Annual Reports
- Management Bios
- News Releases
- Stock Information
- SEC Filings
- Events & Presentations
- Request Information
- Contact Us
Investor Relations
The investor pages that follow are your resource for financial information about Epicept Corporation. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
Corporate Presentation January 2012
[665.3 KB ]
View all »
Recent Releases
Jan 23, 2012
EpiCept Corporation Receives Finalized FDA Guidance for AmiKet™ Phase III CIPN Program and Regulatory Strategy
View all »Events & Presentations
Jan 10, 2012 at 9:30 AM PT
2012 OneMedForum
Jan 9, 2012 at 3:30 PM PT
Biotech Showcase 2012






